Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further

Purpose To evaluate biochemical relapse-free survival (bRFS), overall survival (OS), late rectal and bladder toxicities in a retrospective single institution series, also applying an in-house software for biological dose calculation.